These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 33787986)

  • 1. Water vapor therapy (Rezūm) for lower urinary tract symptoms related to benign prostatic hyperplasia: early results from the first Italian multicentric study.
    Siena G; Cindolo L; Ferrari G; Maruzzi D; Fasolis G; Condorelli SV; Varvello F; Visalli F; Rabito S; Toso S; Caroassai S; Mari A; Viola L; Somani BK; Carini M
    World J Urol; 2021 Oct; 39(10):3875-3880. PubMed ID: 33787986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rezūm water vapor thermal therapy in patients with benign prostatic hyperplasia: Initial real-world data from Japan.
    Obinata D; Mochida J; Uehara R; Osawa M; Hashimoto S; Nakahara K; Yoshizawa T; Yamaguchi K; Takahashi S
    Medicine (Baltimore); 2023 Nov; 102(46):e36055. PubMed ID: 37986385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study.
    McVary KT; Gange SN; Gittelman MC; Goldberg KA; Patel K; Shore ND; Levin RM; Rousseau M; Beahrs JR; Kaminetsky J; Cowan BE; Cantrill CH; Mynderse LA; Ulchaker JC; Larson TR; Dixon CM; Roehrborn CG
    J Sex Med; 2016 Jun; 13(6):924-33. PubMed ID: 27129767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Sexual Function Better Preserved After Water Vapor Thermal Therapy or Medical Therapy for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia?
    McVary KT; Rogers T; Mahon J; Gupta NK
    J Sex Med; 2018 Dec; 15(12):1728-1738. PubMed ID: 30446471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic urethral lift (UroLift) versus convective water vapor ablation (Rezum) for minimally invasive treatment of BPH: a comparison of improvements and durability in 3-year clinical outcomes.
    Elterman D; Shepherd S; Saadat SH; Alshak MN; Bhojani N; Zorn KC; Rijo E; Misrai V; Lajkosz K; Chughtai B
    Can J Urol; 2021 Oct; 28(5):10824-10833. PubMed ID: 34657655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year outcomes after water vapor thermal therapy for symptomatic benign prostatic hyperplasia in an unselected Italian multicenter cohort.
    Cindolo L; Morselli S; Campobasso D; Conti E; Sebastiani G; Franzoso F; Galluccio G; Maruzzi D; Visalli F; Varvello F; Lucci Chiarissi M; Viola L; Sessa F; Toso S; Micali S; Ferrari G; Siena G
    Minerva Urol Nephrol; 2023 Apr; 75(2):203-209. PubMed ID: 36656128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction of Rezum system technology to Ireland for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a pilot study on early outcomes and procedure cost analysis.
    Haroon UM; Khan JS; McNicholas D; Forde JC; Davis NF; Power RE
    Ir J Med Sci; 2022 Feb; 191(1):421-426. PubMed ID: 33599918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rezum water vapor therapy for patients with mild, moderate, or severe lower urinary tract symptoms: A retrospective study in a multiethnic population.
    Babar M; Loloi J; Tang K; Singh S; Ines M; Patel RD; Iqbal N; Ciatto M
    Prostate; 2023 May; 83(7):713-721. PubMed ID: 36879380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rezūm for retention-retrospective review of water vaporization therapy in the management of urinary retention in men with benign prostatic hyperplasia.
    Bassily D; Wong V; Phillips JL; Fraiman M; Bauer R; Dixon CM; Wong NC
    Prostate; 2021 Oct; 81(14):1049-1054. PubMed ID: 34287992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    McVary KT; Gange SN; Gittelman MC; Goldberg KA; Patel K; Shore ND; Levin RM; Rousseau M; Beahrs JR; Kaminetsky J; Cowan BE; Cantrill CH; Mynderse LA; Ulchaker JC; Larson TR; Dixon CM; Roehrborn CG
    J Urol; 2016 May; 195(5):1529-1538. PubMed ID: 26614889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world evidence with The Rezūm System: A retrospective study and comparative analysis on the efficacy and safety of 12 month outcomes across a broad range of prostate volumes.
    Ines M; Babar M; Singh S; Iqbal N; Ciatto M
    Prostate; 2021 Sep; 81(13):956-970. PubMed ID: 34254333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four years of real-world sexual function outcomes after Rezum therapy in men with and without baseline erectile dysfunction.
    Hawks-Ladds N; Cook R; Babar M; Zhu M; Schulz A; Loloi J; Masoud Z; Singh J; Jamil H; Sayed R; Ines M; Ciatto M
    J Sex Med; 2024 Sep; 21(9):777-786. PubMed ID: 39084676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Rezūm System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    Dixon C; Cedano ER; Pacik D; Vit V; Varga G; Wagrell L; Tornblom M; Mynderse L; Larson T
    Urology; 2015 Nov; 86(5):1042-7. PubMed ID: 26216644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of Sexual Function 5 Years After Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia.
    McVary KT; El-Arabi A; Roehrborn C
    Sex Med; 2021 Dec; 9(6):100454. PubMed ID: 34731779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging outcomes of water vapor thermal therapy (Rezum) in a broad range of patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia: A systematic review.
    Babar M; Loloi J; Tang K; Syed U; Ciatto M
    Low Urin Tract Symptoms; 2022 May; 14(3):140-154. PubMed ID: 35233955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Water vapor thermal therapy of lower urinary tract symptoms due to benign prostatic obstruction: efficacy and safety analysis of a real-world cohort of 211 patients.
    Bausch K; Zahiti L; Schrutt M; Wetterauer C; Halbeisen FS; Ebbing J; Seifert HH
    World J Urol; 2023 Jun; 41(6):1605-1612. PubMed ID: 37140664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of benign prostate hyperplasia using the Rezum® water vapor therapy system: Results at one year.
    Alegorides C; Fourmarier M; Eghazarian C; Lebdai S; Chevrot A; Droupy S
    Prog Urol; 2020 Oct; 30(12):624-631. PubMed ID: 32826195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-Year Outcomes of the Prospective, Randomized Controlled Rezūm System Study: Convective Radiofrequency Thermal Therapy for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.
    McVary KT; Roehrborn CG
    Urology; 2018 Jan; 111():1-9. PubMed ID: 29122620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up.
    Porpiglia F; Fiori C; Amparore D; Kadner G; Manit A; Valerio M; Nicolaas L; Ho BSH; Alonso S; Schulman C; Barber N
    BJU Int; 2019 Jun; 123(6):1061-1069. PubMed ID: 30382600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up.
    Porpiglia F; Fiori C; Bertolo R; Garrou D; Cattaneo G; Amparore D
    BJU Int; 2015 Aug; 116(2):278-87. PubMed ID: 25382816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.